FDA drug approval--a lengthy process that delays the availability of important new drugs
Subtitle: report to the Subcommittee on Science, Research, and Technology, House Committee on Science and Technology
By: by the Comptroller General of the United States.
Contributors: United States. Congress. House. Committee on Science and Technology. Subcommittee on Science, Research, and Technology.
Publisher: U.S. General Accounting Office
Published: 1980
Place of publication: Washington, DC
Language: eng
Number of pages: 83
Subjects: United States. Food and Drug Administration; Drug approval -- United States; Drugs -- United States -- Testing; Pharmaceutical industry -- United States -- Quality control
Notes: Cover title.
"May 28, 1980."
"HRB-80-64."
"B-198724."